ProfoundBio
An oncology biotherapeutics company
Woodinville, United States
8 employees
Series B
Total: $247.00M
Biotechnology, Health and Wellness
General Information
Get notified when ProfoundBio moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track ProfoundBio
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United States Market
Biotechnology
About ProfoundBio
Taxonomy: antibody-based therapeutics, clinical-stage, cancer research, ADC drug candidates, solid tumors, hematological malignancies, proprietary technology, Seattle, cancer treatment, innovative drug development, oncology, targeted therapy, precision medicine
Funding Rounds & Investors (4)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series B | •••••• | 1 | •••• •••• | 01 Apr 2024 |
| Series A | •••••• | 7 |
|
01 Jun 2022 |
| Series A | •••••• | 7 |
|
01 Jul 2021 |
| Seed | •••••• | 3 |
|
01 Feb 2021 |
ProfoundBio Alternatives & Competitors
Our mission is to discover and develop life-changing antibody-drug conjugates (ADCs) for patients fi...
Pioneer and Leader in Next Generation Antibody Drug Conjugates Using Engineered Precision Biologics
vs
Oxford BioTherapeutics
FAQ About ProfoundBio
Don't just browse. Track.
Signal Tracker monitors ProfoundBio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.